Cargando…

HIV-1 infection, response to treatment and establishment of viral latency in a novel humanized T cell-only mouse (TOM) model

BACKGROUND: The major targets of HIV infection in humans are CD4(+) T cells. CD4(+) T cell depletion is a hallmark of AIDS. Previously, the SCID-hu thy/liv model was used to study the effect of HIV on thymopoeisis in vivo. However, these mice did not develop high levels of peripheral T cell reconsti...

Descripción completa

Detalles Bibliográficos
Autores principales: Honeycutt, Jenna B, Wahl, Angela, Archin, Nancie, Choudhary, Shailesh, Margolis, David, Garcia, J Victor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826870/
https://www.ncbi.nlm.nih.gov/pubmed/24156277
http://dx.doi.org/10.1186/1742-4690-10-121
_version_ 1782290972602793984
author Honeycutt, Jenna B
Wahl, Angela
Archin, Nancie
Choudhary, Shailesh
Margolis, David
Garcia, J Victor
author_facet Honeycutt, Jenna B
Wahl, Angela
Archin, Nancie
Choudhary, Shailesh
Margolis, David
Garcia, J Victor
author_sort Honeycutt, Jenna B
collection PubMed
description BACKGROUND: The major targets of HIV infection in humans are CD4(+) T cells. CD4(+) T cell depletion is a hallmark of AIDS. Previously, the SCID-hu thy/liv model was used to study the effect of HIV on thymopoeisis in vivo. However, these mice did not develop high levels of peripheral T cell reconstitution and required invasive surgery for infection and analysis. Here, we describe a novel variant of this model in which thy/liv implantation results in systemic reconstitution with human T cells in the absence of any other human hematopoietic lineages. RESULTS: NOD/SCID-hu thy/liv and NSG-hu thy/liv mice were created by implanting human fetal thymus and liver tissues under the kidney capsule of either NOD/SCID or NSG mice. In contrast to NOD/SCID-hu thy/liv mice that show little or no human cells in peripheral blood or tissues, substantial systemic human reconstitution occurs in NSG-hu thy/liv. These mice are exclusively reconstituted with human T cells (i.e. T-cell only mice or TOM). Despite substantial levels of human T cells no signs of graft-versus-host disease (GVHD) were noted in these mice over a period of 14 months. TOM are readily infected after parenteral exposure to HIV-1. HIV replication is sustained in peripheral blood at high levels and results in modest reduction of CD4(+) T cells. HIV-1 replication in TOM responds to daily administration of combination antiretroviral therapy (ART) resulting in strong suppression of virus replication as determined by undetectable viral load in plasma. Latently HIV infected resting CD4(+) T cells can be isolated from suppressed mice that can be induced to express HIV ex-vivo upon activation demonstrating the establishment of latency in vivo. CONCLUSIONS: NSG-hu thy/liv mice are systemically reconstituted with human T cells. No other human lymphoid lineages are present in these mice (i.e. monocytes/macrophages, B cells and DC are all absent). These T cell only mice do not develop GVHD, are susceptible to HIV-1 infection and can efficiently maintain virus replication. HIV infected TOM undergoing ART harbor latently infected, resting CD4(+) T cells.
format Online
Article
Text
id pubmed-3826870
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38268702013-11-14 HIV-1 infection, response to treatment and establishment of viral latency in a novel humanized T cell-only mouse (TOM) model Honeycutt, Jenna B Wahl, Angela Archin, Nancie Choudhary, Shailesh Margolis, David Garcia, J Victor Retrovirology Research BACKGROUND: The major targets of HIV infection in humans are CD4(+) T cells. CD4(+) T cell depletion is a hallmark of AIDS. Previously, the SCID-hu thy/liv model was used to study the effect of HIV on thymopoeisis in vivo. However, these mice did not develop high levels of peripheral T cell reconstitution and required invasive surgery for infection and analysis. Here, we describe a novel variant of this model in which thy/liv implantation results in systemic reconstitution with human T cells in the absence of any other human hematopoietic lineages. RESULTS: NOD/SCID-hu thy/liv and NSG-hu thy/liv mice were created by implanting human fetal thymus and liver tissues under the kidney capsule of either NOD/SCID or NSG mice. In contrast to NOD/SCID-hu thy/liv mice that show little or no human cells in peripheral blood or tissues, substantial systemic human reconstitution occurs in NSG-hu thy/liv. These mice are exclusively reconstituted with human T cells (i.e. T-cell only mice or TOM). Despite substantial levels of human T cells no signs of graft-versus-host disease (GVHD) were noted in these mice over a period of 14 months. TOM are readily infected after parenteral exposure to HIV-1. HIV replication is sustained in peripheral blood at high levels and results in modest reduction of CD4(+) T cells. HIV-1 replication in TOM responds to daily administration of combination antiretroviral therapy (ART) resulting in strong suppression of virus replication as determined by undetectable viral load in plasma. Latently HIV infected resting CD4(+) T cells can be isolated from suppressed mice that can be induced to express HIV ex-vivo upon activation demonstrating the establishment of latency in vivo. CONCLUSIONS: NSG-hu thy/liv mice are systemically reconstituted with human T cells. No other human lymphoid lineages are present in these mice (i.e. monocytes/macrophages, B cells and DC are all absent). These T cell only mice do not develop GVHD, are susceptible to HIV-1 infection and can efficiently maintain virus replication. HIV infected TOM undergoing ART harbor latently infected, resting CD4(+) T cells. BioMed Central 2013-10-24 /pmc/articles/PMC3826870/ /pubmed/24156277 http://dx.doi.org/10.1186/1742-4690-10-121 Text en Copyright © 2013 Honeycutt et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Honeycutt, Jenna B
Wahl, Angela
Archin, Nancie
Choudhary, Shailesh
Margolis, David
Garcia, J Victor
HIV-1 infection, response to treatment and establishment of viral latency in a novel humanized T cell-only mouse (TOM) model
title HIV-1 infection, response to treatment and establishment of viral latency in a novel humanized T cell-only mouse (TOM) model
title_full HIV-1 infection, response to treatment and establishment of viral latency in a novel humanized T cell-only mouse (TOM) model
title_fullStr HIV-1 infection, response to treatment and establishment of viral latency in a novel humanized T cell-only mouse (TOM) model
title_full_unstemmed HIV-1 infection, response to treatment and establishment of viral latency in a novel humanized T cell-only mouse (TOM) model
title_short HIV-1 infection, response to treatment and establishment of viral latency in a novel humanized T cell-only mouse (TOM) model
title_sort hiv-1 infection, response to treatment and establishment of viral latency in a novel humanized t cell-only mouse (tom) model
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826870/
https://www.ncbi.nlm.nih.gov/pubmed/24156277
http://dx.doi.org/10.1186/1742-4690-10-121
work_keys_str_mv AT honeycuttjennab hiv1infectionresponsetotreatmentandestablishmentofvirallatencyinanovelhumanizedtcellonlymousetommodel
AT wahlangela hiv1infectionresponsetotreatmentandestablishmentofvirallatencyinanovelhumanizedtcellonlymousetommodel
AT archinnancie hiv1infectionresponsetotreatmentandestablishmentofvirallatencyinanovelhumanizedtcellonlymousetommodel
AT choudharyshailesh hiv1infectionresponsetotreatmentandestablishmentofvirallatencyinanovelhumanizedtcellonlymousetommodel
AT margolisdavid hiv1infectionresponsetotreatmentandestablishmentofvirallatencyinanovelhumanizedtcellonlymousetommodel
AT garciajvictor hiv1infectionresponsetotreatmentandestablishmentofvirallatencyinanovelhumanizedtcellonlymousetommodel